Ryan Bookout
YOU?
Author Swipe
View article: Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology Open
Hematopoietic cell transplantation (HCT) involves the infusion of hematopoietic progenitor cells into patients with hematologic disorders with the goal of re-establishing normal hematopoietic and immune function. HCT is classified as autol…
View article: IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation Open
Graft-versus-host disease (GvHD) remains a major cause of transplant-related mortality. Interleukin-2 (IL-2) plus sirolimus (SIR) synergistically reduces acute GvHD in rodents and promotes regulatory T cells. This phase II trial tested the…
View article: Characterization of Collaborative Practice Agreements (CPA) Held By Hematopoietic Cell Transplant (HCT) Pharmacists
Characterization of Collaborative Practice Agreements (CPA) Held By Hematopoietic Cell Transplant (HCT) Pharmacists Open
With projected and current workforce shortages within the HCT field, a collaborative approach utilizing the unique skill set of the oncology-trained clinical pharmacist is crucial. Working within an agreed-upon protocol, pharmacists are ab…
View article: Clotrimazole troches induce supratherapeutic blood levels of sirolimus and tacrolimus in an allogeneic hematopoietic cell-transplant recipient resulting in acute kidney injury
Clotrimazole troches induce supratherapeutic blood levels of sirolimus and tacrolimus in an allogeneic hematopoietic cell-transplant recipient resulting in acute kidney injury Open
Allogeneic hematopoietic cell transplantation is a potential curative treatment option for various malignant and nonmalignant hematologic disorders. Patients undergoing an allogeneic hematopoietic cell transplant are prescribed immune-supp…